Hims & Hers Health, Inc.

Fundamentals4.0
Price Action4.0
News Sentiment5.0
AI Rating
4.0

Key Drivers

  • Profitability Decline
  • Liquidity Pressure
  • Rising Leverage

AI
AI Summary

4.0

HIMS is now a margin-recovery and trust-repair investment, not simply a high-growth story: investors should wait for sustained gross-margin stabilization, positive free cash flow, and credible FTC-risk containment before underwriting its strong subscriber and revenue momentum.

SubscriberGrowth
FTCRisk
MarginRecovery‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

4.0

Key Financial Insights:

  • •Profitability Decline
  • •Liquidity Pressure
  • •Rising Leverage

HIMS' sharp shift to quarterly losses, negative cash flow, weaker liquidity, and higher leverage warrants caution despite strong cash reserves and gross profit.

FinancialRisk
ValuationConcern

Price Behavior

4.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • •Lower highs
  • •Support holding
  • •Resistance overhead

HIMS remains bearish over the last month, holding $27.44–$27.51 support but needing to reclaim $29.17 and break $29.60 to improve momentum.

Bearish
Watchlist
Support Level: $27.44–$27.51
Resistance Level: $28.80–$29.00, then $29.58–$29.60

Roughly 12% decline over the last month

Sentiment & News

5.0

Key News Insights:

  • •Revenue acceleration
  • •FTC lawsuit
  • •Margin pressure

HIMS shows strong growth and expansion, but FTC litigation, shareholder claims, and margin pressure raise near-term risk.

Growth
RegulatoryRisk

Strong fundamentals may support long-term upside, but legal and regulatory uncertainty could weigh on HIMS shares near term